Company / Profit Margin
Pacira BioSciences, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
1.0%
FY2025
5-year range
-14.2% / 6.2%
FY2021-FY2025
Trend
+106.8%
vs FY2024
Sector context
#56 of 145
Health Care
What the data says
At 1.0%, Pacira BioSciences, Inc.'s profit margin ranks #56 of 145 in the Health Care sector. Profit Margin has fluctuated over the past 10 years, ranging from -14.9% in FY2019 to 6.2% in FY2023.
Based on SEC 10-K filings.
1.0% in FY2025 with a 5-year CAGR of +1.1%.
Declined from 6.2% to 1.0% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -1.4pp
- 5-Year Change
- +1.1pp
- 10-Year Change
- -
Sector benchmark
#56 of 145 in Health CareTop 39% of 145This company 1.0% Sector average -792.7%
▼
+100.1% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 106.8% year-over-year.
- Currently 793.7pp above the Health Care sector average.
- Peak profit margin was recorded in FY2023.
- Lowest profit margin in the period was in FY2019.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.0% | +106.8% |
| FY2024 | -14.2% | -328.3% |
| FY2023 | 6.2% | +160.3% |
| FY2022 | 2.4% | +191.2% |
| FY2021 | -2.6% | -1771.4% |
| FY2020 | -0.1% | +99.1% |
| FY2019 | -14.9% | -8.3% |
| FY2018 | -13.7% | -1930.7% |
| FY2017 | 0.8% | +105.5% |
| FY2016 | -13.7% | -1930.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026